A prostate cancer biomarker test that utilizes genes indicating high-grade prostate cancer appears highly accurate.
Researchers at the University of Michigan Health Rogel Cancer Center have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow growing form of ...
A study in JAMA Oncology reveals that MyProstateScore 2.0, a new urine test analyzing 18 genes, surpasses PSA in detecting ...
A new prostate cancer test has higher diagnostic accuracy for high-grade disease than current guideline-endorsed biomarkers, ...
The MyProstateScore 2.0 urine test captures 17 biomarkers of clinically significant prostate cancer, independent of PSA. A positive result can rule in and a negative result can rule out the need for ...
Researchers at the University of Michigan Rogel Cancer Center have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the ...
While the initial study focused on head and neck cancer, the team also analyzed urine samples of people with other cancers, ...
A new urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically ...
When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the only ...